69 related articles for article (PubMed ID: 14737782)
1. [Two cases of severe sepsis successfully treated with activated protein C].
Aguirre Caballero A; Gutiérrez-Jodra Gamboa A; García Pérez Del Río JI; Lavilla Díaz M
Rev Esp Anestesiol Reanim; 2003 Dec; 50(10):539-43. PubMed ID: 14737782
[TBL] [Abstract][Full Text] [Related]
2. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
[TBL] [Abstract][Full Text] [Related]
3. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA
Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of activated protein C in real-life clinical practice.
Dhainaut JF; Payet S; Vallet B; França LR; Annane D; Bollaert PE; Le Tulzo Y; Runge I; Malledant Y; Guidet B; Le Lay K; Launois R;
Crit Care; 2007; 11(5):R99. PubMed ID: 17822547
[TBL] [Abstract][Full Text] [Related]
5. The use of recombinant human activated protein C (rhAPC) in the treatment of severe sepsis in immunosuppressed patients in the course of hematological diseases.
Kunsdorf-Wnuk A; Marzec-Lewenstein E; Arct-Danielak D; Musioł E; Bohatyrewicz R; Becht R
Med Sci Monit; 2005 Aug; 11(8):CS49-55. PubMed ID: 16049385
[TBL] [Abstract][Full Text] [Related]
6. Severe sepsis in a premature neonate: protein C replacement therapy.
De Carolis MP; Polimeni V; Papacci P; Lacerenza S; Romagnoli C
Turk J Pediatr; 2008; 50(4):405-8. PubMed ID: 19014060
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human activated protein C for severe sepsis in a neonate.
Rawicz M; Sitkowska B; Rudzińska I; Kornacka MK; Bocheński P
Med Sci Monit; 2002 Nov; 8(11):CS90-4. PubMed ID: 12444386
[TBL] [Abstract][Full Text] [Related]
8. Use of activated protein C in liver transplantation patients with septic shock.
Rinaldi L; Marietta M; Mignini MA; Donno L; Busani S; Codeluppi M; Masetti M; Girardis M
Liver Transpl; 2008 Nov; 14(11):1598-602. PubMed ID: 18972572
[TBL] [Abstract][Full Text] [Related]
9. Use of protein C concentrate in pediatric patients with sepsis.
Silvani P; Camporesi A; Licari E; Wolfler A
Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C: controversy and hope in the treatment of sepsis.
Baillie JK
Curr Opin Investig Drugs; 2007 Nov; 8(11):933-8. PubMed ID: 17979027
[TBL] [Abstract][Full Text] [Related]
11. Natural anticoagulant inhibitors: activated Protein C.
Aird WC
Best Pract Res Clin Haematol; 2004 Mar; 17(1):161-82. PubMed ID: 15171965
[TBL] [Abstract][Full Text] [Related]
12. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
Baratto F; Michielan F; Gagliardi G; Di Gregorio G; Pasqualetto A; Meroni M; Giron GP
Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
[TBL] [Abstract][Full Text] [Related]
13. [Protein C concentrate in the treatment of severe sepsis in the pediatric setting].
Ramos Guerrero R; López Castilla JD; Atienza Fernández M; Bautista Paloma J; Ramos Guerrero AJ; Muñoz Sáez M; Carranza Conde M; Soult Rubio JA
Farm Hosp; 2003; 27(6):391-5. PubMed ID: 14974885
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant human activated protein C in treatment of severe sepsis in a pregnant patient with fully symptomatic ovarian hyperstimulation syndrome.
Mikaszewska-Sokolewicz M; Mayzner-Zawadzka E
Med Sci Monit; 2005 Jun; 11(6):CS27-32. PubMed ID: 15917724
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study.
de Pont AC; Bakhtiari K; Hutten BA; de Jonge E; Vroom MB; Meijers JC; Büller HR; Levi M
Crit Care; 2005 Oct; 9(5):R490-7. PubMed ID: 16277710
[TBL] [Abstract][Full Text] [Related]
16. [Exogenous activated protein C in severe sepsis].
Mamontova OA; Protsenko DN; Eliutin DV; Kirienko PN; Gel'fand BR
Anesteziol Reanimatol; 2005; (3):42-5. PubMed ID: 16076046
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.
Ghani RA; Zainudin S; Ctkong N; Rahman AF; Wafa SR; Mohamad M; Manaf MR; Ismail R
Nephrology (Carlton); 2006 Oct; 11(5):386-93. PubMed ID: 17014550
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.
Hensley LE; Stevens EL; Yan SB; Geisbert JB; Macias WL; Larsen T; Daddario-DiCaprio KM; Cassell GH; Jahrling PB; Geisbert TW
J Infect Dis; 2007 Nov; 196 Suppl 2():S390-9. PubMed ID: 17940975
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis.
Maybauer MO; Maybauer DM; Fraser JF; Traber LD; Westphal M; Enkhbaatar P; Cox RA; Huda R; Hawkins HK; Morita N; Murakami K; Mizutani A; Herndon DN; Traber DL
Crit Care Med; 2006 Sep; 34(9):2432-8. PubMed ID: 16810106
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C for the treatment of severe sepsis.
Houston G; Cuthbertson BH
Clin Microbiol Infect; 2009 Apr; 15(4):319-24. PubMed ID: 19416303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
